Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.430
+0.070 (5.15%)
At close: May 13, 2025, 4:00 PM
1.460
+0.030 (2.10%)
Pre-market: May 14, 2025, 5:14 AM EDT
Repare Therapeutics Employees
Repare Therapeutics had 129 employees as of December 31, 2024. The number of employees decreased by 50 or -27.93% compared to the previous year.
Employees
129
Change (1Y)
-50
Growth (1Y)
-27.93%
Revenue / Employee
$414,550
Profits / Employee
-$656,504
Market Cap
60.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RPTX News
- 15 hours ago - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results - Business Wire
- 13 days ago - Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates - Business Wire
- 13 days ago - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics - Business Wire
- 18 days ago - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025 - Business Wire
- 6 weeks ago - Repare Therapeutics Announces Leadership Transitions - Business Wire
- 2 months ago - Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 months ago - Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions - Business Wire